Search by Drug Name or NDC

    NDC 11822-0117-01 lansoprazole 15 mg/1 Details

    lansoprazole 15 mg/1

    lansoprazole is a ORAL CAPSULE, DELAYED RELEASE in the HUMAN OTC DRUG category. It is labeled and distributed by Rite Aid Corporation. The primary component is LANSOPRAZOLE.

    Product Information

    NDC 11822-0117
    Product ID 11822-0117_eb135721-6c37-43fb-b093-16efa2acde4d
    Associated GPIs 97709030006300
    GCN Sequence Number 000652
    GCN Sequence Number Description guaifenesin/dextromethorphan LIQUID 100-10MG/5 ORAL
    HIC3 B3T
    HIC3 Description NON-OPIOID ANTITUSSIVE AND EXPECTORANT COMBINATION
    GCN 53491
    HICL Sequence Number 000223
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR
    Brand/Generic Generic
    Proprietary Name lansoprazole
    Proprietary Name Suffix n/a
    Non-Proprietary Name Lansoprazole
    Product Type HUMAN OTC DRUG
    Dosage Form CAPSULE, DELAYED RELEASE
    Route ORAL
    Active Ingredient Strength 15
    Active Ingredient Units mg/1
    Substance Name LANSOPRAZOLE
    Labeler Name Rite Aid Corporation
    Pharmaceutical Class Inhibition Gastric Acid Secretion [PE], Proton Pump Inhibitor [EPC], Proton Pump Inhibitors [MoA]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202319
    Listing Certified Through 2023-12-31

    Package

    NDC 11822-0117-01 (11822011701)

    NDC Package Code 11822-0117-1
    Billing NDC 11822011701
    Package 1 BOTTLE in 1 CARTON (11822-0117-1) / 14 CAPSULE, DELAYED RELEASE in 1 BOTTLE
    Marketing Start Date 2012-05-18
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 24a4fb29-d5bb-4f44-bd79-cbc47c1e5536 Details

    Revised: 12/2018